Valcon Medical has reached another significant milestone with the successful implementation of a consistent supply chain to United Kingdom
In United Kingdom Medicinal Cannabis is classified as an unlicensed medicine/Specials and manufactured to meet a specific patient’s clinical needs. Valcon Medical offers exciting partnership opportunities for standardised cannabis oil brands in the United Kingdom.
COPENHAGEN, DENMARK June 15, 2023 - Valcon Medical, a renowned and trusted provider of medicinal cannabis in the United Kingdom, is actively seeking new and innovative partnerships with companies interested in introducing standardised cannabis oil under their brand. As medicinal cannabis is classified as an unlicensed medicine/Specials in the UK, Valcon Medical specialises in manufacturing cannabis oil tailored to meet patients' specific clinical need.
Valcon Medical takes great pride in offering homogenous, high-quality, standardised cannabis oil manufactured under the strictest adherence to Good Manufacturing Practices (GMP). With a strong focus on compliance, the company meticulously tailors a solid regulatory package that adheres to all necessary guidelines and standards for importing cannabis medicines globally.
The regulatory framework surrounding medicinal cannabis in the United Kingdom has significantly changed in recent years. In November 2018, the UK government rescheduled cannabis-based medicinal products, allowing specialist doctors to legally prescribe them to patients with certain medical conditions. Under the current regulatory framework, medicinal cannabis is classified as an unlicensed medicine or Specials in the UK. This means it is not subject to the same level of regulation as licensed medicines. However, it is still subject to strict guidelines and standards to ensure patient safety and product quality.
"We understand the critical importance of providing patients with reliable and effective medicinal cannabis products," said Peter Emil Sigetty, COO for Valcon Medical. "By partnering with us, companies can leverage our extensive regulatory expertise and tap into our reliable supply chain to ensure that patients in need have access to the highest quality cannabis oil."
Valcon Medical's commitment to excellence extends beyond manufacturing. The company places great emphasis on building strong and mutually beneficial partnerships. By collaborating with Valcon Medical, companies can tap into their extensive knowledge of regulations and benefit from their established supply chain to deliver medicinal cannabis to patients in need. In addition to their regulatory expertise, Valcon Medical also offers comprehensive support in navigating the complex landscape of the medicinal cannabis industry. Their team of experts is well-versed in the ever-evolving regulations and can provide valuable guidance to partners, ensuring compliance and success in the market.
To import and distribute medicinal cannabis in the UK, companies must adhere to Good Manufacturing Practices (GMP). This ensures that the cannabis oil is manufactured under strict quality control measures and meets the necessary standards for safety, efficacy, and consistency.
Valcon Medical, as a trusted provider of medicinal cannabis in the UK, places great emphasis on compliance with the regulatory framework. They meticulously tailor a solid regulatory package that adheres to all necessary guidelines and standards for the import of cannabis medicines globally. This ensures that their cannabis oil products meet the highest quality standards and are safe for patients.
In addition to compliance with GMP, companies operating in the medicinal cannabis industry must also navigate the complex regulations surrounding the import, distribution, and prescription of cannabis-based medicines. Valcon Medical offers comprehensive support and advice to partners in navigating these regulations. Their team of experts is well-versed in the ever-evolving regulatory environment and can provide valuable guidance to ensure compliance and success in the market.
Overall, the regulatory framework for medicinal cannabis in the United Kingdom is evolving, and companies like Valcon Medical are at the forefront of ensuring compliance and providing patients with reliable access to high-quality cannabis oil. Through partnerships and collaboration, the industry can continue to grow and contribute to the well-being of patients in need.
About Valcon Medical
Valcon Medical is a leading and trusted provider of medicinal cannabis extracts and standardised oils globally. With a strong focus on compliance and regulatory expertise, they specialise in manufacturing high-quality cannabis oil that meets the specific clinical needs of patients. Valcon Medical's commitment to excellence extends beyond manufacturing, as they offer comprehensive support and guidance to partners in navigating the complex landscape of the medicinal cannabis industry.
Valcon Medical invites interested parties to contact them at firstname.lastname@example.org to discuss the exciting possibilities of partnering up. By joining forces with Valcon Medical, companies can not only establish their own brand of standardised cannabis oil but also contribute to the well-being of patients by providing them with reliable access to high-quality medicinal cannabis products.
For more information about Valcon Medical and their services, please visit their website at www.valcon-medical.com.
You might also be interested in
Valcon Medical is proud to announce its new partnership agreement with a well reputed Polish manufacturer of medicinal cannabis
Introduction of medicinal cannabis to the Polish market requires a marketing authorisation for a pharmaceutical raw material to prepare prescription drugs in the form of non-fibrous hemp herbs, extracts, and tinctures.
The European Pharmacopoeia Commission (EPC) has adopted a new European monograph for Cannabis flower
The European Pharmacopoeia Commission has adopted a new European monograph for Cannabis flower at the latest Commission meeting in June 2023. The monograph describes quality requirements for the raw material Cannabis flower.
ENEXIS makes an investment in Denmark-based medical cannabis group Valcon Medical
Valcon Medical Closes Series C Round and Launches Global Commercial Sales of Medical Cannabis Products - Funding led by Altitude Investment Management, Artemis Growth Partners, and Enexis AB, increases total capital raised to €11.8 million.